Advertisement

Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry)

      Compared with heart failure (HF) with reduced ejection fraction (HF-REF), the diagnosis of HF with preserved EF (HF-PEF) is more challenging. The aim of the study was to assess the prevalence of HF-PEF among patients hospitalized for HF, to evaluate the pertinence of HF-PEF diagnosis and to compare HF-PEF and HF-REF patients with respect to outcomes. The analysis included 661 Polish patients hospitalized for HF, selected from the European Society of Cardiology (ESC)-HF Long-Term Registry. Patients with an EF of ≥50% were included in the HF-PEF group and patients with an EF of <50% - in the HF-REF group. The primary end point was all-cause death at 1 year. The secondary end point was a composite of all-cause death and rehospitalization for HF at 1 year. HF-PEF was present in 187 patients (28%). Of those 187 patients, mitral inflow pattern was echocardiographically assessed in 116 patients (62%) and classified as restrictive/pseudonormal in 37 patients (20%). Compared with HF-REF subjects, patients with HF-PEF were older, more often female, and had a higher prevalence of hypertension, atrial fibrillation and sleep apnea. Despite lower B-type natriuretic peptide concentrations and lower prevalence of moderate-to-severe mitral regurgitation in patients with HF-PEF, congestive symptoms at admission were as severe as in patients with HF-REF. There were no significant differences in in-hospital mortality between the HF groups. One-year mortality was high in both groups (17% in HF-PEF vs 21% in HF-REF, p = 0.22). There was a trend toward a lower frequency of the secondary end point in the HF-PEF group (32% vs 40%, p = 0.07). In conclusion, in clinical practice, even easily obtainable echocardiographic indexes of diastolic dysfunction are relatively rarely acquired. One-year survival rate of patients with HF-PEF is not significantly better than that of patients with HF-REF.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Steinberg B.A.
        • Zhao X.
        • Heidenreich P.A.
        • Peterson E.D.
        • Bhatt D.L.
        • Cannon C.P.
        • Hernandez A.F.
        • Fonarow G.C.
        • Get With the Guidelines Scientific Advisory Committee and Investigators
        Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.
        Circulation. 2012; 126: 65-75
        • Owan T.E.
        • Hodge D.O.
        • Herges R.M.
        • Jacobsen S.J.
        • Roger V.L.
        • Redfield M.M.
        Trends in prevalence and outcome of heart failure with preserved ejection fraction.
        N Engl J Med. 2006; 355: 251-259
        • Shah S.J.
        • Katz D.H.
        • Deo R.C.
        Phenotypic spectrum of heart failure with preserved ejection fraction.
        Heart Fail Clin. 2014; 10: 407-418
        • Nagueh S.F.
        • Appleton C.P.
        • Gillebert T.C.
        • Marino P.N.
        • Oh J.K.
        • Smiseth O.A.
        • Waggoner A.D.
        • Flachskampf F.A.
        • Pellikka P.A.
        • Evangelisa A.
        Recommendations for the evaluation of left ventricular diastolic function by echocardiography.
        Eur J Echocardiogr. 2009; 10: 165-193
        • Nagueh S.F.
        • Smiseth O.A.
        • Appleton C.P.
        • Byrd 3rd, B.F.
        • Dokainish H.
        • Edvardsen T.
        • Flachskampf F.A.
        • Gillebert T.C.
        • Klein A.L.
        • Lancellotti P.
        • Marino P.
        • Oh J.K.
        • Popescu B.A.
        • Waggoner A.D.
        Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
        J Am Soc Echocardiogr. 2016; 29: 277-314
        • McMurray J.J.
        • Adamopoulos S.
        • Anker S.D.
        • Auricchio A.
        • Böhm M.
        • Dickstein K.
        • Falk V.
        • Filippatos G.
        • Fonseca C.
        • Gomez-Sanchez M.A.
        • Jaarsma T.
        • Køber L.
        • Lip G.Y.
        • Maggioni A.P.
        • Parkhomenko A.
        • Pieske B.M.
        • Popescu B.A.
        • Rønnevik P.K.
        • Rutten F.H.
        • Schwitter J.
        • Seferovic P.
        • Stepinska J.
        • Trindade P.T.
        • Voors A.A.
        • Zannad F.
        • Zeiher A.
        • ESC Committee for Practice Guidelines
        ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012.
        Eur Heart J. 2012; 33: 1787-1847
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • Butler J.
        • Casey Jr., D.E.
        • Drazner M.H.
        • Fonarow G.C.
        • Geraci S.A.
        • Horwich T.
        • Januzzi J.L.
        • Johnson M.R.
        • Kasper E.K.
        • Levy W.C.
        • Masoudi F.A.
        • McBride P.E.
        • McMurray J.J.
        • Mitchell J.E.
        • Peterson P.N.
        • Riegel B.
        • Sam F.
        • Stevenson L.W.
        • Tang W.H.
        • Tsai E.J.
        • Wilkoff B.L.
        • American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
        2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.
        Circulation. 2013; 128: e240-e327
        • Massie B.M.
        • Carson P.E.
        • McMurray J.J.
        • Komajda M.
        • McKelvie R.
        • Zile M.R.
        • Anderson S.
        • Donovan M.
        • Iverson E.
        • Staiger C.
        • Ptaszynska A.
        • I-PRESERVE Investigators
        Irbesartan in patients with heart failure and preserved ejection fraction.
        N Engl J Med. 2008; 359: 2456-2467
        • Maggioni A.P.
        • Anker S.D.
        • Dahlström U.
        • Filippatos G.
        • Ponikowski P.
        • Zannad F.
        • Amir O.
        • Chioncel O.
        • Leiro M.C.
        • Drozdz J.
        • Erglis A.
        • Fazlibegovic E.
        • Fonseca C.
        • Fruhwald F.
        • Gatzov P.
        • Goncalvesova E.
        • Hassanein M.
        • Hradec J.
        • Kavoliuniene A.
        • Lainscak M.
        • Logeart D.
        • Merkely B.
        • Metra M.
        • Persson H.
        • Seferovic P.
        • Temizhan A.
        • Tousoulis D.
        • Tavazzi L.
        • Heart Failure Association of the ESC
        Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
        Eur J Heart Fail. 2013; 15: 1173-1184
        • Quiroz R.
        • Doros G.
        • Shaw P.
        • Liang C.S.
        • Gauthier D.F.
        • Sam F.
        Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
        Am J Cardiol. 2014; 113: 691-696
        • Bhatia R.S.
        • Tu J.V.
        • Lee D.S.
        • Austin P.C.
        • Fang J.
        • Haouzi A.
        • Gong Y.
        • Liu P.P.
        Outcome of heart failure with preserved ejection fraction in a population-based study.
        N Engl J Med. 2006; 355: 260-269
        • Tsuchihashi-Makaya M.
        • Hamaguchi S.
        • Kinugawa S.
        • Yokota T.
        • Goto D.
        • Yokoshiki H.
        • Kato N.
        • Takeshita A.
        • Tsutsui H.
        • JCARE-CARD Investigators
        Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).
        Circ J. 2009; 73: 1893-1900
        • Fonarow G.C.
        • Stough W.G.
        • Abraham W.T.
        • Albert N.M.
        • Gheorghiade M.
        • Greenberg B.H.
        • O’Connor C.M.
        • Sun J.L.
        • Yancy C.W.
        • Young J.B.
        Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry.
        J Am Coll Cardiol. 2007; 50: 768-777
        • Yancy C.W.
        • Lopatin M.
        • Stevenson L.W.
        • De Marco T.
        • Fonarow G.C.
        Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database.
        J Am Coll Cardiol. 2006; 47: 76-84
        • Lenzen M.J.
        • Scholte op Reimer W.J.
        • Boersma E.
        • Vantrimpont P.J.
        • Follath F.
        • Swedberg K.
        • Cleland J.
        • Komajda M.
        Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey.
        Eur Heart J. 2004; 25: 1214-1220
        • Hammoudi N.
        • Charbonnier M.
        • Levy P.
        • Djebbar M.
        • Stankovic Stojanovic K.
        • Ederhy S.
        • Girot R.
        • Cohen A.
        • Isnard R.
        • Lionnet F.
        Left atrial volume is not an index of left ventricular diastolic dysfunction in patients with sickle cell anaemia.
        Arch Cardiovasc Dis. 2015; 108: 156-162
        • Altekin R.E.
        • Yanikoglu A.
        • Karakas M.S.
        • Ozel D.
        • Yilmaz H.
        • Demir I.
        Evaluation of left atrial function using two-dimensional speckle tracking echocardiography in end-stage renal disease patients with preserved left ventricular ejection fraction.
        Kardiol Pol. 2013; 71: 341-351
        • Klein A.L.
        • Burstow D.J.
        • Tajik A.J.
        • Zachariah P.K.
        • Bailey K.R.
        • Seward J.B.
        Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons.
        Mayo Clin Proc. 1994; 69: 212-224
        • Ozierański K.
        • Kapłon-Cieślicka A.
        • Peller M.
        • Tymińska A.
        • Balsam P.
        • Galas M.
        • Marchel M.
        • Crespo-Leiro M.
        • Maggioni A.P.
        • Drożdż J.
        • Opolski G.
        Clinical characteristics and predictors of one-year outcome of heart failure patients with atrial fibrillation compared to heart failure patients in sinus rhythm.
        Kardiol Pol. 2016; 74: 251-261
        • Iwano H.
        • Little W.C.
        Heart failure: what does ejection fraction have to do with it?.
        J Cardiol. 2013; 62: 1-3
        • Lam C.S.
        • Donal E.
        • Kraigher-Krainer E.
        • Vasan R.S.
        Epidemiology and clinical course of heart failure with preserved ejection fraction.
        Eur J Heart Fail. 2011; 13: 18-28
        • Wan S.H.
        • Vogel M.W.
        • Chen H.H.
        Pre-clinical diastolic dysfunction.
        J Am Coll Cardiol. 2014; 63: 407-416
        • Kraigher-Krainer E.
        • Shah A.M.
        • Gupta D.K.
        • Santos A.
        • Claggett B.
        • Pieske B.
        • Zile M.R.
        • Voors A.A.
        • Lefkowitz M.P.
        • Packer M.
        • McMurray J.J.
        • Solomon S.D.
        • PARAMOUNT Investigators
        Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
        J Am Coll Cardiol. 2014; 63: 447-456
        • Mentz R.J.
        • Kelly J.P.
        • von Lueder T.G.
        • Voors A.A.
        • Lam C.S.
        • Cowie M.R.
        • Kjeldsen K.
        • Jankowska E.A.
        • Atar D.
        • Butler J.
        • Fiuzat M.
        • Zannad F.
        • Pitt B.
        • O'Connor C.M.
        Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.
        J Am Coll Cardiol. 2014; 64: 2281-2293
        • Desai A.
        • Fang J.C.
        Heart failure with preserved ejection fraction: hypertension, diabetes, obesity/sleep apnea, and hypertrophic and infiltrative cardiomyopathy.
        Heart Fail Clin. 2008; 4: 87-97
        • Chan M.M.
        • Lam C.S.
        How do patients with heart failure with preserved ejection fraction die?.
        Eur J Heart Fail. 2013; 15: 604-613
        • Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
        The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.
        Eur Heart J. 2012; 33: 1750-1757
        • Alla F.
        • Al-Hindi A.Y.
        • Lee C.R.
        • Schwartz T.A.
        • Patterson J.H.
        • Adams Jr., K.F.
        Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction.
        Am Heart J. 2007; 153: 1074-1080
        • Haass M.
        • Kitzman D.W.
        • Anand I.S.
        • Miller A.
        • Zile M.R.
        • Massie B.M.
        • Carson P.E.
        Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
        Circ Heart Fail. 2011; 4: 324-331
        • Bavishi C.
        • Ather S.
        • Bambhroliya A.
        • Jneid H.
        • Virani S.S.
        • Bozkurt B.
        • Deswal A.
        Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
        Am J Cardiol. 2014; 113: 1834-1838